Truveris
United States
- Wilmington, Delaware
- 15/05/2024
- Series E
- $15,000,000
Truveris is a pharmacy benefits procurement and insights platform, combining technology and expertise to revolutionize access and affordability of
prescription drugs.
For more information or to speak with a representative, please contact us at: info@truveris.com.
- Industry Hospital & Health Care
- Website https://truveris.com/
- LinkedIn https://www.linkedin.com/company/truveris/
Related People
Nanette OddoFounder
United States -
Wilmington, Delaware
C-Suite executive with experience in new business launches, operational execution, strategic growth and operations at scale. Experience ranges from start-up through successful exits with venture capital, private equity backed companies including fundraising, merger and acquisition and IPO experience. Domestic and international healthcare expertise in payer, provider, employer managed care and life sciences. Key areas of experiences include:
• Board governance
• Strategic Growth
• Fundraising and M&A transactions
• Driving Performance and scale
• Compliance
• Team Building; attracting and developing talent
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)